New analytical methodology in assessing comparability of biosimilars
Julia Ding
Khairia M Youssef and Eric J Lien
Risk assessment with the help of failure mode and effects analysis (FMEA) in BE studies
Kateryna Zupanets
Some aspects of clinical trials on bioequivalence studies
Kateryna Zupanets, Igor Zupanets, Sergij Popov, Nataliya Bezugla and Olena Andrieieva
Muneesh Garg, Raghu Naidu, Krishnan Iyer, Ratnakar Jadhav and Amolkumar Birhade
Muneesh Garg, Raghu Naidu, Krishnan Iyer, Ratnakar Jadhav and Amolkumar Birhade
Prasugrel effect on in vitro bleeding time tests in a single dose bioequivalence study
Ahmet Inal and Zafer Sezer
Audits and inspections- bioavailability and bioequivalence studies
Bipin Patel
The use of asymmetric distributions in average bioequivalence
Roberto Molina de Souza, Jorge A Achcar, Edson Z Martinez and Josmar Mazucheli
Stephen Tindal
Starch-guar gum extrudates: Microstructure, physicochemical properties and in vitro digestion
Erich von Borries Medrano, Monica R Jaime Fonseca and Miguel A Aguilar Mendez
Overview of bioavailability/bioequivalence clinical trials in a phase 1 in Turkey
Zafer Sezer, Ahmet Inal, Mumtaz Mazicioglu and Aydin Erenmemisoglu
Sue Duran, Rosemary Cummings, Eva Abarca, W R Ravis, Y J Lin, Allison Stewart and Jennifer Koziol
Structural approaches for targeted therapy
Somdutta Saha